Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinhuang Gel is a topical Traditional Chinese Medicine (TCM) formulation developed by Jiangsu Kanion Pharmaceutical Co., Ltd. for the treatment of acute soft tissue injuries, such as ankle sprains. It is a modern gel adaptation of the classic "Ruyi Jinhuang San" formula, which is traditionally used to clear heat, resolve toxins, and reduce swelling. The formulation contains extracts from ten herbal components, including *Curcumae Longae Rhizoma* (Turmeric), *Phellodendri Chinensis Cortex*, and *Rhei Rhizoma*. Pharmacologically, Jinhuang Gel exhibits anti-inflammatory and analgesic properties by inhibiting the production of pro-inflammatory cytokines (e.g., TNF-alpha, IL-1beta) and enzymes (e.g., COX-2), thereby alleviating local pain and edema. It is currently in Phase III clinical development in China for indications involving "toxic heat" and "blood stasis" patterns in acute injuries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinhuang Gel.